News

Promising new way to modulate brain cell activity to potentially treat major depressive disorder in adults. ScienceDaily . Retrieved June 11, 2025 from www.sciencedaily.com / releases / 2025 / 05 ...
Roughly one in ten Americans suffers from major depressive disorder (MDD) at any given time. In total, up to 20 percent of ...
The major depressive disorder medication, BHV-7000, is different than those that focus on serotonin because it focuses on potassium channels, which help regulate the activity of neurons in the brain.
Topline data were announced from a phase 3 trial evaluating navacaprant for the treatment of major depressive disorder (MDD). Navacaprant is a highly selective kappa opioid receptor (KOR ...
Major depressive disorder impacts peripheral artery disease risk through intermediary risk factors. J Am Heart Assoc . 2024 Feb 20;13(4):e030233. doi: 10.1161/JAHA.123.030233. Epub 2024 Feb 16.
Rates of depression notably spiked during the pandemic. But even though life has largely returned to normal, we’re still in a mental health crisis. In 2023, the U.S. Surgeon General declared an ...
Source Reference: Butterfield NN, et al "Azetukalner, a novel K V 7 potassium channel opener, in adults with major depressive disorder: a randomized clinical trial" JAMA Netw Open 2025; DOI: 10. ...
The biomarker-defined MDD patient group treated with ALTO-100 did not demonstrate a statistically significant improvement in depressive symptoms compared to placebo.
But this year, the U.S. Food and Drug Administration cleared the first app-based treatment for major depressive disorder, which just became available for use this summer.
Study: Exploration of first onsets of mania, schizophrenia spectrum disorders and major depressive disorder in perimenopause.Image Credit: SpeedKingz/Shutterstock.com. Background. Perimenopause ...
The major depressive disorder medication, BHV-7000, is different than those that focus on serotonin because it focuses on potassium channels, which help regulate the activity of neurons in the brain.